We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-0.4%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.89B
AUM Growth
+$247M
Cap. Flow
+$292M
Cap. Flow %
15.46%
Top 10 Hldgs %
4.59%
Holding
2,016
New
495
Increased
552
Reduced
502
Closed
447

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$8.87M
2
NTES icon
NetEase
NTES
+$5.4M
3
AAPL icon
Apple
AAPL
+$5.21M
4
LPX icon
Louisiana-Pacific
LPX
+$5.15M
5
PPL
PPL Corp
PPL
+$4.72M

Sector Composition

Rank Sector Weight
1 Industrials 14.39%
2 Consumer Discretionary 13.89%
3 Financials 13.63%
4 Technology 12.57%
5 Healthcare 11.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDIT icon
751
Editas Medicine
EDIT
$442M
$871K 0.05%
+26,285
New +$937K
THFF icon
752
First Financial Corp
THFF
$969M
$869K 0.05%
20,900
-3,000
-13% -$135K
MCHP icon
753
Microchip Technology
MCHP
$46B
$868K 0.05%
+19,012
New +$876K
RYN icon
754
Rayonier
RYN
$6.55B
$868K 0.05%
27,181
-22,600
-45% -$687K
ROCC
755
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$868K 0.05%
24,778
+11,299
+84% +$450K
MRC
756
DELISTED
MRC Global
MRC
$867K 0.05%
52,734
-1,474
-3% -$25.8K
PGRE
757
DELISTED
Paramount Group
PGRE
$865K 0.05%
+60,756
New +$886K
FBP icon
758
First Bancorp
FBP
$4.38B
$862K 0.05%
143,179
+131,590
+1,135% +$775K
CRSP icon
759
CRISPR Therapeutics
CRSP
$5.17B
$861K 0.05%
18,831
-61,769
-77% -$2.55M
TFC icon
760
Truist Financial
TFC
$64B
$860K 0.05%
+16,524
New +$890K
EMES
761
DELISTED
Emerge Energy Services LP
EMES
$858K 0.05%
139,462
-62,835
-31% -$489K
ASIX icon
762
AdvanSix
ASIX
$444M
$856K 0.05%
24,620
-14,277
-37% -$563K
HAE icon
763
Haemonetics
HAE
$4B
$855K 0.05%
+11,687
New +$802K
MTG icon
764
MGIC Investment
MTG
$6.25B
$854K 0.05%
65,729
-110,175
-63% -$1.56M
ADAP
765
DELISTED
Adaptimmune Therapeutics
ADAP
$852K 0.05%
+75,912
New +$664K
CMPR icon
766
Cimpress
CMPR
$2.31B
$851K 0.05%
+5,500
New +$819K
IDXX icon
767
Idexx Laboratories
IDXX
$46.2B
$850K 0.05%
4,442
-3,002
-40% -$554K
MDP
768
DELISTED
Meredith Corporation
MDP
$850K 0.05%
+15,799
New +$939K
RNST icon
769
Renasant Corp
RNST
$3.91B
$847K 0.04%
19,905
+14,246
+252% +$613K
MYE icon
770
Myers Industries
MYE
$1.29B
$844K 0.04%
39,900
+10,200
+34% +$211K
AKAM icon
771
Akamai
AKAM
$16.1B
$839K 0.04%
11,815
+5,429
+85% +$370K
MCRN
772
DELISTED
Milacron Holdings Corp.
MCRN
$839K 0.04%
41,674
-76,583
-65% -$1.51M
CTRN icon
773
Citi Trends
CTRN
$605M
$838K 0.04%
+27,095
New +$663K
WU icon
774
Western Union
WU
$2.21B
$838K 0.04%
43,580
+11,040
+34% +$222K
APC
775
DELISTED
Anadarko Petroleum
APC
$837K 0.04%
13,851
-20,411
-60% -$1.2M

Similar funds

GSA Capital Partners's Q1 2018 Portfolio in Review

As of Q1 2018, GSA Capital Partners held 2,016 positions worth $1.89B, up 15% from $1.64B the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.

GSA Capital Partners deployed $292M of net new capital in Q1 2018, opening 495 new positions and adding to 552 existing holdings. Its largest new stake was Dominion Energy: 167,074 shares worth $11.3M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Applied Materials, an estimated $8.87M trimmed.

  • GSA Capital Partners's largest Q1 2018 buy was Dominion Energy: 167,074 shares worth $11.3M.
  • GSA Capital Partners added most to TransUnion in Q1 2018, an estimated $8.34M increase.
  • GSA Capital Partners's biggest Q1 2018 reduction was Applied Materials, cutting an estimated $8.87M.
  • GSA Capital Partners fully exited NetEase in Q1 2018, selling an estimated $5.4M.
  • GSA Capital Partners's ten largest holdings make up 4.6% of its $1.89B portfolio in Q1 2018.
  • GSA Capital Partners opened 495 new positions and closed 447 in Q1 2018.
  • GSA Capital Partners's portfolio value rose 15% quarter-over-quarter to $1.89B.

Based on GSA Capital Partners's 13F filing for Q1 2018, filed 11 May 2018.